DRibble vaccine

BIOLOGICAL4 trials

Sponsors

Providence Health & Services, UbiVac, Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions

Adenocarcinoma of the ProstateCarcinoma, Non-Small-Cell LungNon Small Cell Lung Cancer

Phase 1

Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung Cancer

CompletedNCT00850785

Providence Health & ServicesNon Small Cell Lung Cancer

Start: 2009-01-31End: 2012-05-31Updated: 2016-09-27

Pilot Study of DRibble Vaccine for Prostate Cancer Patients

CompletedNCT02234921

UbiVacAdenocarcinoma of the Prostate

Start: 2014-10-24End: 2018-08-15Updated: 2018-10-11

The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityCarcinoma, Non-Small-Cell Lung

Start: 2017-06-01End: 2020-12-01Target: 30Updated: 2017-02-20

Phase 2

Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer

CompletedNCT01909752

UbiVacCarcinoma, Non-Small-Cell Lung

Start: 2013-07-31End: 2017-04-30Updated: 2017-07-06

Related Papers

A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer

Journal for ImmunoTherapy of Cancer2017-12-0116 citations

T cell population expansion in response to allogeneic cancer vaccine alone (DPV-001) or with granulocyte-macrophage colony-stimulating factor (GM-CSF) or imiquimod (I) for definitively-treated stage III NSCLC patients (pts).

Journal of Clinical Oncology2017-05-205 citations